Skip to main content
editorial
. 2006 Nov 7;12(41):6715–6721. doi: 10.3748/wjg.v12.i41.6715

Table 4.

Response to treatment between thymosin-a1 & IFN-a groups

At the end of therapy OR (95% CI) At the end of follow-up OR (95% CI)
ALT normalization 0.65 (0.21, 2.01) 3.19 (1.02, 10.61)a
HBVDNA-negation 0.62 (0.19, 1.94) 3.94 (1.23, 13.69)b
HBeAg-negation 0.55 (0.17, 1.72) 2.45 (0.77, 8.23)
ALT normal/ HBeAg & HBVDNA-negation 0.55 (0.17, 1.72) 2.45 (0.77, 8.23)
a

P < 0.05,

b

P < 0.01 vs IFN-α.